CYANOACETIC ACID-OSU
CYANOACETIC ACID-OSU Basic information
- Product Name:
- CYANOACETIC ACID-OSU
- Synonyms:
-
- CYANOACETIC ACID-OSU
- Succinimidyl Cyanoacetate
- Acetic acid, 2-cyano-, 2,5-dioxo-1-pyrrolidinyl ester
- 2,5-Dioxopyrrolidin-1-yl 2-cyanoacetate
- 2,5-Dioxopyrrolidin-1-yl cyanoacetate
- 2,5-Pyrrolidinedione, 1-[(cyanoacetyl)oxy]-
- N-(Cyanoacetoxy)succinimide
- Cyanoacetic acid 2,5-dioxopyrrolidin-1-yl ester
- CAS:
- 56657-76-2
- MF:
- C7H6N2O4
- MW:
- 182.13
- EINECS:
- 1592732-453-0
- Mol File:
- 56657-76-2.mol
More
Less
CYANOACETIC ACID-OSU Chemical Properties
- Boiling point:
- 336.1±44.0 °C(Predicted)
- Density
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- DMSO (Slightly)
- form
- solid
- pka
- 0.74±0.10(Predicted)
- color
- White
- Stability:
- Very Moisture Sensitive
More
Less
CYANOACETIC ACID-OSU Usage And Synthesis
Uses
Cyanoacetic Acid N-Hydroxysuccinimide Ester is used as a pharmaceutical intermediate. It is used in the preparation of substituted pyrrolopyrimidinamines as selective Janus kinase inhibitors for the treatment of autoimmune diseases and organ transplant rejection.
CYANOACETIC ACID-OSUSupplier
Krain Pharmaceutical Technology CO.,Ltd Gold
- Tel
- 18252089365
- Krain_kerun@163.com
NANJING DAOGE BIOPHARMA CO.,LTD. Gold
- Tel
- 025-58227606 18021503536
- sale@daogepharm.com
Beijing Lunarsun Pharmaceutical Co.,LTD.
- Tel
- 86-10-64911848-8020.8010
- sales@lunarsun.com.cn
Shanghai Hanhong Scientific Co.,Ltd.
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
Syntechem Co.,Ltd
- Tel
- info@syntechem.com
More
Less
CYANOACETIC ACID-OSU(56657-76-2)Related Product Information
- Tofacitinib impurity T
- 3-Piperidinamine,4-methyl-1-(phenylmethyl)-,(3R,4R)-rel-
- methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine
- Methyl thioglycolate
- 2-Ethylhexyl mercaptoacetate
- 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)-
- Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate
- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib
- 4-(Hydroxyamino)-4-oxobutanoic acid
- N-Hydroxysuccinimide
- Tofacitinib Impurity 2
- N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
- N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
- Tofacitinib Impurity 29